A tumor’s immune response to a single dose of the HER2 inhibitor trastuzumab predicted which patients with HER2-positive breast cancer would respond to the drug on a more long-term basis, according to the results of a new study.
from Top Health News – ScienceDaily http://bit.ly/1LtpFff via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1TOlr36
No comments:
Post a Comment